OpenAlex
PricingAboutJobs
Log inGet started
Work

Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer

HTML PDF

Year: 2011
Type: article
Source: Journal of Thoracic Oncology
DOI: 10.1097/jto.0b013e3182307f98
Authors: Koichi Goto, Yukito Ichinose, Yuichiro Ohe, Nobuyuki Yamamoto, Shunichi Negoro, Kazuto Nishio, Yohji Itoh, Haiyi Jiang, Emma Duffield, Rose McCormack, Nagahiro Saijo, Tony Mok, Masahiro Fukuoka
Institutions: National Cancer Center Hospital East, National Hospital Organization Kyushu Cancer Center, National Cancer Center Hospital, Shizuoka Cancer Center, Kindai University Hospital, Kindai University, AstraZeneca (Japan), AstraZeneca (United Kingdom), Chinese University of Hong Kong
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: EGFR mutation status, cell-free DNA, serum, non-small cell lung cancer, lung adenocarcinoma, gefitinib, carboplatin-paclitaxel, false-negative results, progression-free survival, objective response rate
SDG: Good health and well-being

Open Access status: bronze

Funder: AstraZeneca
OpenAlex ID: W1978527867
FWCI: 13.26
Cites: 17
Cited by: 216
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security